Section Arrow
Quote
HSDT.NASDAQ
- Helius Medical Technologies
(Financial Status)
Quotes are at least 15-min delayed:2025/04/30 04:50 EDT
Last
 0.283
-0.0163 (-5.45%)
Day High 
0.326999 
Prev. Close
0.2993 
1-M High
0.4889 
Volume 
75.95K 
Bid
0.283
Ask
0.3
Day Low
0.2807 
Open
0.30855 
1-M Low
0.26 
Market Cap 
1.83M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.29 
20-SMA 0.32 
50-SMA 0.4 
52-W High 4.2 
52-W Low 0.26 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.33/3.14
Enterprise Value
1.83M
Balance Sheet
Book Value Per Share
0.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
787.00K
Operating Revenue Per Share
0.14
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/30 04:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.